Browse Pet Safety Reports
1,332,683 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,332,683 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,332,683 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 26, 2026 | Dog | Terrier - Bull - American Pit | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 26, 2026 | Dog | Terrier - Yorkshire | Bedinvetmab | Pollakiuria; Seizure NOS | Ongoing |
| Feb 26, 2026 | Dog | Beagle, Dog (unknown) | Bedinvetmab | Vomiting; Ataxia; Inappropriate urination; Disorientation; Hearing decreased;... | Ongoing |
| Feb 26, 2026 | Dog | Shepherd (unspecified), Dog... | Oclacitinib Maleate | Seizure NOS | Ongoing |
| Feb 26, 2026 | Cat | Persian | Selamectin;Sarolaner | Wobbliness; Seizure NOS; Other abnormal test result NOS | Ongoing |
| Feb 26, 2026 | Dog | Crossbred Canine/dog, Chihu... | Fluralaner Powder For Inj Susp | Injection site hair loss; Injection site reddening | Ongoing |
| Feb 26, 2026 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Hind limb ataxia; Polyuria; Polydipsia; Weakness; Not eating; Elevated blood ... | Ongoing |
| Feb 26, 2026 | Cat | Cat (unknown) | Bexagliflozin | Lack of efficacy - NOS | Outcome Unknown |
| Feb 26, 2026 | Dog | Crossbred Canine/dog | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea; Lack of efficacy (ectoparasite) - tic... | Ongoing |
| Feb 26, 2026 | Dog | Collie - Border | Pyrantel Pamoate;Sarolaner | Aggression; Behavioural disorder NOS; Shaking; Diarrhoea; Decreased appetite;... | Recovered/Normal |
| Feb 26, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Elevated betahydroxybutyrate (BHBA); Elevated fructosamine | Outcome Unknown |
| Feb 26, 2026 | Dog | Pit Bull | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (protozoa) - Giardia; Lack of efficacy (endoparasite) - roun... | Outcome Unknown |
| Feb 26, 2026 | Cat | Domestic Shorthair | Milbemycin Oxime | Suckling disorder NOS; Licking; Skin scab; Peripheral vascular disorder; Pinn... | Outcome Unknown |
| Feb 26, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Hyperglycaemia; Elevated betahydroxybutyrate (BHBA) | Ongoing |
| Feb 26, 2026 | Cat | Domestic Shorthair | Thiamazole | Facial swelling (see also Skin) | Recovered/Normal |
| Feb 26, 2026 | Dog | Crossbred Canine/dog, Sheph... | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 25, 2026 | Dog | Maltese, Terrier - Yorkshire | Cefpodoxime Proxetil | Application site inflammation; Application site reddening | Outcome Unknown |
| Feb 25, 2026 | Dog | Retriever - Labrador | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Feb 25, 2026 | Dog | Collie (unspecified), Dog (... | Bedinvetmab | Drooling; Cough; Panting | Ongoing |
| Feb 25, 2026 | Dog | Pointing Dog - German Short... | Bedinvetmab | Lack of efficacy - NOS; Pain NOS; Circling - neurological disorder (see also ... | Ongoing |
| Feb 25, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; Polyuria; Hypothyroidism; Azotaemia; Polydipsia; Hyperphosphataemi... | Ongoing |
| Feb 25, 2026 | Dog | Pug, Beagle | Maropitant Citrate | Vomiting; Discomfort NOS; Mopey; Not eating | Ongoing |
| Feb 25, 2026 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Bedinvetmab | Musculoskeletal disorder NOS; Aggression; Unable to walk; Urinary incontinenc... | Euthanized |
| Feb 25, 2026 | Dog | Bulldog - English, Dog (unk... | Bedinvetmab | Injection site pain; Injection site swelling; Lethargy (see also Central nerv... | Died |
| Feb 25, 2026 | Dog | Spaniel - King Charles Cava... | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Feb 25, 2026 | Dog | Terrier - Bull - American P... | Bedinvetmab | Cognitive disorder NOS; Behavioural disorder NOS; Staring; Confusion | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Powder For Inj Susp | Head shake - behavioural disorder; Pruritus; Soft stool; Blood in faeces; Col... | Recovered with Sequela |
| Feb 25, 2026 | Dog | Spaniel - Cocker English | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Boxer (German Boxer) | Carprofen | Injection site swelling | Outcome Unknown |
| Feb 25, 2026 | Dog | Bulldog - French | Moxidectin | Emesis (multiple); Facial swelling (see also Skin); Hypersensitivity reaction... | Ongoing |
| Feb 25, 2026 | Dog | Spaniel - King Charles Cava... | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Feb 25, 2026 | Dog | Shepherd Dog - German | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 25, 2026 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 25, 2026 | Horse | Unknown | Hyaluronate Sodium Neogenvet Hycoat H... | Fungal skin infection NOS | Outcome Unknown |
| Feb 24, 2026 | Dog | Collie - Border | Pyrantel Pamoate;Sarolaner | Ataxia; Vomiting | Recovered/Normal |
| Feb 24, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Emesis (multiple); Itching; Diarrhoea | Outcome Unknown |
| Feb 24, 2026 | Cat | Domestic Shorthair | Protamine Zinc Recombinant Human Insulin | INEFFECTIVE, GLYCEMIC CONTROL; INEFFECTIVE, LOSS OF EFFECT | Outcome Unknown |
| Feb 24, 2026 | Dog | Pointing Dog - German (unsp... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Star-gazing | Recovered/Normal |
| Feb 24, 2026 | Dog | Retriever - Golden | Pyrantel Pamoate;Sarolaner | Seizure NOS; Twitching; Pacing; Tongue protrusion; Foam in the mouth; Behavio... | Recovered/Normal |
| Feb 24, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 24, 2026 | Dog | Pug | Tigilanol Tiglate | Death; Injection site swelling; Injection site discharge NOS; Injection site ... | Died |
| Feb 24, 2026 | Dog | Shepherd Dog - German | Ivermectin; Pyrantel | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 24, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Medication error NOS | Ongoing |
| Feb 24, 2026 | Dog | Pit Bull, Dog (unknown) | Ilunocitinib | Vulvovaginitis; Vaginal discharge | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.